News
Brief news reports on Tuberculosis
By
Treatment Action Group
Published: March 29, 2023, 8:09 p.m.·
Tags:
Vaccines
Treatment Action Group (TAG) will host a webinar on 13 April 2023 that will provide an overview of the TB vaccine pipeline, based on TAG’s recent Tuberculosis Vaccines Pipeline Report, including the different candidates at different stages of research, and ongoing and upcoming studies that advocates should closely follow.
Read More →
By
1/4/6x24 Campaign Coalition
Published: March 28, 2023, 6:34 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
The Indian Patent Office takes a laudable step that will pave the way for generic manufacturing of a key TB drug.
Read More →
By
TB Vax ARM
Published: March 27, 2023, 11:36 p.m.·
Tags:
Vaccines,
Research and development,
Advocacy
Global TB community calls on world leaders to increase political and financial commitments to develop and roll out new TB vaccines as a central part of the global TB response.
Read More →
By
International Union Against Tuberculosis and Lung Disease
Published: March 27, 2023, 9:40 p.m.·
Tags:
Pediatrics
On 4 April 2023, the International Union Against Tuberculosis and Lung Disease (The Union) will host a webinar 'We must find TB, to end TB' to share its expertise, experience, and resources on TB in children and adolescents.
Read More →
By
Global TB Caucus
Published: March 24, 2023, 11:30 p.m.·
Tags:
Global TB response,
Advocacy
To commemorate World TB Day, the Global TB Caucus produced three videos to briefly discuss TB: giving context on the current status of the epidemic, discussing how work in the sphere is currently ongoing, what role the Caucus plays in the fight against TB, and how audiences might involve themselves in the cause. The Caucus adopted a creative approach to make the video messages more accessible to all audiences. Access the video series here.
Read More →
By
Unitaid
Published: March 24, 2023, 10:43 p.m.·
Tags:
Prevention,
Treatment,
Access
Johannesburg, 24 March 2023 – The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced today that it will provide 250,000 patient courses of short course rifapentine-based preventive treatment regimens to seven countries to help prevent tuberculosis (TB). The patient courses will include the three-month 3HP regimen, and the even shorter 1HP, that is only taken for 28 days. This contribution is part of the Consortium’s ongoing efforts to end TB and improve global health outcomes.
Read More →
By
ECDC,
WHO/Europe
Published: March 24, 2023, 9:45 p.m.·
Tags:
TB epidemiology
On World TB Day 2023, ECDC and WHO/Europe issue a sobering warning that, despite having the tools to end TB, the European Region remains a long way from meeting its End TB Strategy targets.
Read More →
By
UNAIDS
Published: March 24, 2023, 9:21 p.m.·
Tags:
HIV coinfection,
Advocacy
Today, on World TB Day, we must recognize the urgent need to end the TB epidemic around the world, especially among people living with HIV.
Read More →
By
Peter Sands
Published: March 23, 2023, 9:41 p.m.·
Tags:
Global TB response,
Advocacy
Q: When do we ignore a deadly pandemic?
A: When it’s called tuberculosis (TB)
Read More →
Page 59 of 895 · Total posts: 10
←First
58
59
60
Last→